Retention of clinical biosamples / blank matrices [Regulatives / Guidelines]

posted by ElMaestro  – Belgium?, 2019-04-23 18:15  – Posting: # 20212
Views: 970

Hi jag,

» "we can always ask the CRO to extended the stability" :confused:

"...if we stored the samples along with appropriate QC's."

The thing is regulators throw a curve ball every now and then. Sometimes there is even a degree of rationale behind it. If the study is inspected or someone asks for re-analysis or any other activity of this type then you simply have much better chances of answering if you have the samples and the QCs still frozen.
CRO compliance suddenly questioned by an evil inspector? Send the B-set to another CRO, show BE with those samples, and Bob's your uncle!

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Admin contact
20,103 posts in 4,243 threads, 1,383 registered users;
online 13 (2 registered, 11 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 10:02 CET

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5